Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate - PubMed (original) (raw)
. 2005 Jun 3;280(22):21155-61.
doi: 10.1074/jbc.M413183200. Epub 2005 Mar 15.
Affiliations
- PMID: 15769751
- DOI: 10.1074/jbc.M413183200
Free article
Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate
Laurens A van Meeteren et al. J Biol Chem. 2005.
Free article
Abstract
Autotaxin (ATX) or nucleotide pyrophosphatase/phosphodiesterase 2 (NPP2) is an NPP family member that promotes tumor cell motility, experimental metastasis, and angiogenesis. ATX primarily functions as a lysophospholipase D, generating the lipid mediator lysophosphatidic acid (LPA) from lysophosphatidylcholine. ATX uses a single catalytic site for the hydrolysis of both lipid and non-lipid phosphodiesters, but its regulation is not well understood. Using a new fluorescence resonance energy transfer-based phosphodiesterase sensor that reports ATX activity with high sensitivity, we show here that ATX is potently and specifically inhibited by LPA and sphingosine 1-phosphate (S1P) in a mixed-type manner (Ki approximately 10(-7) M). The homologous ecto-phosphodiesterase NPP1, which lacks lysophospholipase D activity, is insensitive to LPA and S1P. Our results suggest that, by repressing ATX activity, LPA can regulate its own biosynthesis in the extracellular environment, and they reveal a novel role for S1P as an inhibitor of ATX, in addition to its well established role as a receptor ligand.
Similar articles
- Anticancer activity of FTY720: phosphorylated FTY720 inhibits autotaxin, a metastasis-enhancing and angiogenic lysophospholipase D.
van Meeteren LA, Brinkmann V, Saulnier-Blache JS, Lynch KR, Moolenaar WH. van Meeteren LA, et al. Cancer Lett. 2008 Aug 8;266(2):203-8. doi: 10.1016/j.canlet.2008.02.052. Epub 2008 Apr 18. Cancer Lett. 2008. PMID: 18378389 Free PMC article. - Kinetic analysis of autotaxin reveals substrate-specific catalytic pathways and a mechanism for lysophosphatidic acid distribution.
Saunders LP, Cao W, Chang WC, Albright RA, Braddock DT, De La Cruz EM. Saunders LP, et al. J Biol Chem. 2011 Aug 26;286(34):30130-41. doi: 10.1074/jbc.M111.246884. Epub 2011 Jun 30. J Biol Chem. 2011. PMID: 21719699 Free PMC article. - Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate.
Clair T, Aoki J, Koh E, Bandle RW, Nam SW, Ptaszynska MM, Mills GB, Schiffmann E, Liotta LA, Stracke ML. Clair T, et al. Cancer Res. 2003 Sep 1;63(17):5446-53. Cancer Res. 2003. PMID: 14500380 - Regulation of lysophosphatidate signaling by autotaxin and lipid phosphate phosphatases with respect to tumor progression, angiogenesis, metastasis and chemo-resistance.
Samadi N, Bekele R, Capatos D, Venkatraman G, Sariahmetoglu M, Brindley DN. Samadi N, et al. Biochimie. 2011 Jan;93(1):61-70. doi: 10.1016/j.biochi.2010.08.002. Epub 2010 Aug 13. Biochimie. 2011. PMID: 20709140 Review. - Therapeutic potential of autotaxin/lysophospholipase d inhibitors.
Federico L, Pamuklar Z, Smyth SS, Morris AJ. Federico L, et al. Curr Drug Targets. 2008 Aug;9(8):698-708. doi: 10.2174/138945008785132439. Curr Drug Targets. 2008. PMID: 18691016 Free PMC article. Review.
Cited by
- Improving the Pharmacodynamics and In Vivo Activity of ENPP1-Fc Through Protein and Glycosylation Engineering.
Stabach PR, Zimmerman K, Adame A, Kavanagh D, Saeui CT, Agatemor C, Gray S, Cao W, De La Cruz EM, Yarema KJ, Braddock DT. Stabach PR, et al. Clin Transl Sci. 2021 Jan;14(1):362-372. doi: 10.1111/cts.12887. Epub 2020 Oct 20. Clin Transl Sci. 2021. PMID: 33064927 Free PMC article. - Overexpression of autotaxin is associated with human renal cell carcinoma and bladder carcinoma and their progression.
Xu A, Ahsanul Kabir Khan M, Chen F, Zhong Z, Chen HC, Song Y. Xu A, et al. Med Oncol. 2016 Nov;33(11):131. doi: 10.1007/s12032-016-0836-7. Epub 2016 Oct 18. Med Oncol. 2016. PMID: 27757783 - Role of Adipose Tissue-Derived Autotaxin, Lysophosphatidate Signaling, and Inflammation in the Progression and Treatment of Breast Cancer.
Brindley DN, Tang X, Meng G, Benesch MGK. Brindley DN, et al. Int J Mol Sci. 2020 Aug 18;21(16):5938. doi: 10.3390/ijms21165938. Int J Mol Sci. 2020. PMID: 32824846 Free PMC article. Review. - Carba analogs of cyclic phosphatidic acid are selective inhibitors of autotaxin and cancer cell invasion and metastasis.
Baker DL, Fujiwara Y, Pigg KR, Tsukahara R, Kobayashi S, Murofushi H, Uchiyama A, Murakami-Murofushi K, Koh E, Bandle RW, Byun HS, Bittman R, Fan D, Murph M, Mills GB, Tigyi G. Baker DL, et al. J Biol Chem. 2006 Aug 11;281(32):22786-93. doi: 10.1074/jbc.M512486200. Epub 2006 Jun 16. J Biol Chem. 2006. PMID: 16782709 Free PMC article. - Sphingosine-1-Phosphate in the Tumor Microenvironment: A Signaling Hub Regulating Cancer Hallmarks.
Riboni L, Abdel Hadi L, Navone SE, Guarnaccia L, Campanella R, Marfia G. Riboni L, et al. Cells. 2020 Feb 1;9(2):337. doi: 10.3390/cells9020337. Cells. 2020. PMID: 32024090 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous